Gadolinium: Clinical Trials

5 trials of Gadolinium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn, 1 active not recruiting, 1 completed, 1 terminated. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Withdrawn 2, Active not recruiting 1, Completed 1, Terminated 1

Follow Gadolinium: new trials by email Literature Review of Gadolinium trials Research Report on Gadolinium

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ELUDYN: Assessment of Intra-individual Variability of Vascular Dynamics of Gadopiclenol Injection Parameters in Contrast-enhanced MRI
contrast agent, Gadolinium - Contrast Agent, Medical Imaging Data
Phase 4Active not recruitingHôpital Fribourgeois142026-01-072026-04-29
Use of Gadolinium in CT Pulmonary Angiography
Gadolinium - Pulmonary Embolism
Phase 4WithdrawnMassachusetts General Hospital2017-07-012020-02-17
A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography
Gadolinium - Contrast Media Allergy
Phase 4WithdrawnMassachusetts General Hospital2016-12-012021-05-04
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease
Gadolinium - Meniere's Disease
Phase 4TerminatedUniversity Hospital, Grenoble232016-03-162020-11-18
Stress Cardiac MRI for Evaluation of Nonspecific Allograft Dysfunction
Regadenoson, Gadolinium, Cardiac MRI - Heart Transplant, Acute Graft Rejection
Phase 4CompletedPaul Kim142015-11-012017-08-22

Conditions studied

Meniere Disease (1)  ·  Pulmonary Embolism (1)

Sponsors

Massachusetts General Hospital (2)  ·  Hôpital Fribourgeois (1)  ·  Paul Kim (1)  ·  University Hospital, Grenoble (1)

Countries

United States (3)  ·  France (1)  ·  Switzerland (1)

Top investigators

Amita Sharma, MD (1)  ·  Paul J Kim, MD (1)

NIH funding

2025 (1)